Covered recipient · General Payments record
SARA GOREE CHAPMAN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$887.01
- Reported across 55 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $199.89 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $82.17 | 5 |
| Silk Road Medical, Inc. | $36.41 | 1 |
| Amgen Inc. | $19.18 | 1 |
| Acerta Pharma LLC | $17.19 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $15.87 | 1 |
| Lilly USA, LLC | $15.28 | 1 |
| ABBVIE INC. | $13.79 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $13.79 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106903614 | CMS |
| Amgen Inc. | $19.18 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117524579 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.19 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104438391 | CMS |
| Lilly USA, LLC | $15.28 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135861662 | CMS |
| Novo Nordisk Inc | $17.80 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100487831 | CMS |
| Novo Nordisk Inc | $19.12 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100556109 | CMS |
| Novo Nordisk Inc | $13.09 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100464086 | CMS |
| Novo Nordisk Inc | $16.58 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100547196 | CMS |
| Novo Nordisk Inc | $15.58 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100421037 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $15.87 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153478308 | CMS |
| Silk Road Medical, Inc. | $36.41 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082262352 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.